We serve L-TYROSINE CAS:60-18-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
L-TYROSINE
CAS:60-18-4
| Abbreviation | L-Tyr |
| Chemical Name | (S)-2-Amino-3-(4-hydroxyphenyl) Propionic Acid |
| Chemical Formula | C9H11NO3 |
| Molecular Weight | 181.19 |
| Nitrogen Content | 7.73% |
| CAS Number | 60-18-4 |
| Conforms To | USP, EP, JP |
| Solubility | Practically insoluble in water |
| Assay | 99.0% to 101.0% |
| Specification | White crystals or crystalline powder; tasteless |
| Country of Origin | China |
| Manufacturing Process | Fermentation |
| Packaging | 1 kg, 10 kg poly pail, 25 kg fiber drum |
| Additional Information | Tyrosine is a non-essential amino acid. It is a precursor to dopamine and other adrenomedullary hormones, an important factor in regulating mood. Tyrosine is involved in the metabolism of the amino acid phenylalanine and has been used to ease headaches, stress, anxiety and chemical addictions. |
Contact us for information like L-TYROSINE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Sivlor physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Tyr Use and application,Paschol technical grade,usp/ep/jp grade.
Related News: We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries.5-Chloro-4-methoxy-2-oxo-1,2-dihydropyridine-3-carbonitrile manufacturer Also that day the CDC reported the first case of person-to-person transmission in Illinois between household members.2,3-Dimethylphenyl isothiocyanate supplier Also that day the CDC reported the first case of person-to-person transmission in Illinois between household members.4-Methylbenzoic acid vendor Dr. John K. Westwick, CEO of Resonant, added “Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates.Dr. John K. Westwick, CEO of Resonant, added “Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates.
